| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | CA2411961C Novel process for the preparation of pyrazolopyrimidinones |
| 02/01/2007 | WO2007014290A2 Fungicidal carboxamides |
| 02/01/2007 | WO2007014198A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders |
| 02/01/2007 | WO2007013830A1 Nitrocatechol derivatives as comt inhibitors |
| 02/01/2007 | WO2007013743A1 Method of preparing esomeprazole and salts thereof |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013098A1 A process for the preparation of almotriptan |
| 02/01/2007 | WO2007012900A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | WO2007012849A2 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 02/01/2007 | WO2007012651A1 Isotopically substituted pantoprazole |
| 02/01/2007 | WO2007012650A1 Isotopically substituted proton pump inhibitors |
| 02/01/2007 | WO2007012479A2 Benzylpiperazine derivates and their medical use |
| 02/01/2007 | WO2007012421A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | WO2006129120A3 Benzotriazepinone derivatives |
| 02/01/2007 | WO2006122156A3 Compounds for modulating trpv3 function |
| 02/01/2007 | WO2006086609A3 Inhibitors of tryptase |
| 02/01/2007 | WO2006050162A3 Imidazole derivatives |
| 02/01/2007 | WO2006000336A9 Anthranilamides serving as pesticides |
| 02/01/2007 | WO2005090329A9 New compounds for the inhibition of angiogenesis and use of thereof |
| 02/01/2007 | US20070027325 Process for the preparation of cilostazol and of the intermediates thereof |
| 02/01/2007 | US20070027321 Bipyridyl amines and ethers as modulators of metabotropic glutamate receptor-5 |
| 02/01/2007 | US20070027318 Quinoline derivatives and quinazoline derivatives |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027186 Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
| 02/01/2007 | US20070027183 Inhibitors of microsomal triglyceride transfer protein and apo-B secretion |
| 02/01/2007 | US20070027174 Phenylalanine Enamide Derivatives |
| 02/01/2007 | US20070027161 Central nervous system disorders, Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease (enhancement of cognitive memory), sleep disorders, feeding disorders such as anorexia |
| 02/01/2007 | US20070027159 Therapeutic agents useful for treating pain |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
| 02/01/2007 | US20070027155 Biaryl piperazinyl-pyridine analogues |
| 02/01/2007 | US20070027147 Biarylurea derivatives |
| 02/01/2007 | US20070027145 Quinazoline derivatives as inhibitors of vegf receptor tyrosine kinases |
| 02/01/2007 | US20070027140 {2-[(1-cyclopropylmethyl-6-fluoro-1H-indole-3-carbonyl)-amino]-thiazol-5-ylsulfanyl}-acetic acid, used for treating non-insulin dependent diabetes, dyslipidemia, hyperlipidemia, hypertension, obesity and as dietetics |
| 02/01/2007 | US20070027132 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 02/01/2007 | US20070027131 N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine; antiinflammatory, antiarthritic agents |
| 02/01/2007 | US20070027118 Novel compounds of amino sulfonyl derivatives |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070023628 Labeling agents for mass spectrometry comprising tertiary amines |
| 02/01/2007 | DE102005014904A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2616985A1 Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-i-yl methylene or a pyrimidin-2yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
| 02/01/2007 | CA2616547A1 Quinoline derivatives as neurokinin receptor antagonists |
| 02/01/2007 | CA2616513A1 Benzylpiperazine derivates useful for the treatment of gastrointestinal disorders |
| 02/01/2007 | CA2616377A1 Nitrocatechol derivatives as comt inhibitors |
| 02/01/2007 | CA2615678A1 Isotopically substituted pantoprazole |
| 02/01/2007 | CA2615670A1 Isotopically substituted proton pump inhibitors |
| 02/01/2007 | CA2615577A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 02/01/2007 | CA2614919A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of proliferative disorders |
| 02/01/2007 | CA2614288A1 Fungicidal carboxamides |
| 01/31/2007 | EP1748045A1 Light-emitting device material and light-emitting device |
| 01/31/2007 | EP1747222A1 Pyrimidine derivatives antagonists of vitronectin receptor |
| 01/31/2007 | EP1747215A1 Substantially pure 2-{¬2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carbonyl|-amino}-3-(phenylpyridin-2-yl-amino)-propionic acid as an ikb kinase inhibitor |
| 01/31/2007 | EP1747206A1 Amino-tetrazoles analogues and methods of use |
| 01/31/2007 | EP1747204A1 Tri-substituted ureas as cytokine inhibitors |
| 01/31/2007 | EP1747203A1 Scalable synthesis of imidazole derivatives |
| 01/31/2007 | EP1747201A1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1746999A1 4-phenylamino-quinazolin-6-yl-amides |
| 01/31/2007 | EP1746997A2 3-(4-heteroarylcyclohexylamino) czclopentanecarboxamides as modulators of chemokine receptors |
| 01/31/2007 | EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
| 01/31/2007 | EP1509516B1 Inhibitors of the gpib -vwf interaction, their preparation and use |
| 01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
| 01/31/2007 | CN1906189A 1-acetic acid-indole, -indazole and-benzimidazole derivatives usful for the treatment of respiratory disorders |
| 01/31/2007 | CN1906188A Phenyl-[4-(3-phenyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-amine derivatives as IGF-1R inhibitors |
| 01/31/2007 | CN1906187A 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5 |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1906178A 喹唑啉衍生物 Quinazoline derivatives |
| 01/31/2007 | CN1906176A Therapeutic agents II |
| 01/31/2007 | CN1906174A Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 01/31/2007 | CN1906172A Pyrazolyl derivatives in the form of drugs for treating acute or chronic neuronal regressions |
| 01/31/2007 | CN1906171A Substituted azole compounds, preparation and application thereof |
| 01/31/2007 | CN1906169A Therapeutic agents I |
| 01/31/2007 | CN1906168A Methods and compositions for selectin inhibition |
| 01/31/2007 | CN1906167A Novel pyridine derivative and pyrimidine derivative (2) |
| 01/31/2007 | CN1906166A Novel pyridine derivative and pyrimidine derivative (1) |
| 01/31/2007 | CN1906165A Novel herbicides |
| 01/31/2007 | CN1906163A 4-phenylpiperidine derivatives as renin inhibitors |
| 01/31/2007 | CN1905884A Pyrazole derivatives as inhibitors of receptor tyrosyne kinases |
| 01/31/2007 | CN1905882A Vascular intimal hyperplasia inhibitor |
| 01/31/2007 | CN1905881A Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1905872A Amino substituted pyridinyl methanone compounds useful in treating kinase disorders |
| 01/31/2007 | CN1905868A DPP-IV inhibitors |
| 01/31/2007 | CN1903846A Ornidazole derivative used for therapy, its preparation method and use |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/30/2007 | US7169951 Quinazoline derivatives and pharmaceutical applications thereof |
| 01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/30/2007 | US7169927 Heterocyclic amides or prodrugs used in the treatment of diabetes, insulin resistance, metabolic disorders and obesity |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169924 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |